Fatigue, low ferritin, and a coach-planned altitude camp
An elite 24-year-old female cyclist reports persistent fatigue and declining 20-minute power over the past 6 weeks. She trains 18–20 h/week and has a heavy menstrual bleed lasting 6 days each cycle. Bloods show ferritin 18 µg/L, hemoglobin 118 g/L, CRP 2.1 mg/L, and transferrin saturation 16%; she is not anemic by laboratory cutoff but says her legs feel empty. Her coach wants a 3-week altitude camp at 2,300 m starting in 10 days and has suggested an iron injection before departure. She eats mixed diet, reports no GI bleeding, and currently takes no supplements. The team physician is on leave. You have her training files, menstrual history, and a nutrition recall, but no recent performance testing beyond power data.
1. How should you interpret the iron and performance data, and what is the immediate priority before approving altitude?
Read the worked answer
Interpretation. Ferritin 18 µg/L is low for a cyclist with this load, but CRP 2.1 mg/L can inflate ferritin, so the true iron picture may be worse; TSAT 16% is also low. Hb 118 g/L does not by itself confirm iron-deficiency anemia, and fatigue plus declining power is nonspecific. Heavy menstrual bleeding is a plausible driver, but GI loss and other causes need medical review. Priority. Do not approve an iron injection or altitude camp on these data alone. Refer to the team physician or a sports physician for a full workup, including repeat ferritin with CRP, CBC, and a plan for menstrual blood loss; the athlete should not start high-dose iron without supervision. Altitude raises iron demand and can worsen symptoms, so the camp should be conditional on medical clearance and a clear iron plan. Your role is to quantify performance risk, document the data, and communicate uncertainty-not to diagnose or prescribe.
2. What 10-day monitoring and communication plan would you set with the coach and athlete?
Read the worked answer
10-day plan. With physician agreement: day 0–2, medical review and nutrition assessment; day 2–4, repeat labs if advised and confirm menstrual history; day 4–7, trial of prescribed oral iron if appropriate, with adherence and GI tolerance checks; day 7–10, decide on camp using symptom, Hb/ferritin trend, and training tolerance. Track daily wellness, sleep, bleed volume, resting HR, and submaximal power at fixed cadence. Set red flags: worsening breathlessness, palpitations, dizziness, or unexplained power loss. Communication. Tell the coach that altitude is a stressor, not a treatment, and that injection is not a quick fix. Offer a contingency: delay camp, shorten it, or reduce altitude/load. Re-test power only when the athlete is symptomatically stable. Document that decisions are shared with the physician and athlete, and avoid promising a performance timeline.
3. If the athlete is medically cleared and the camp proceeds, what adjustments and data would you use?
Read the worked answer
If cleared and camp proceeds. Reduce initial altitude load by 20–30% for the first 3–4 days and avoid adding intensity while symptoms are monitored. Use power at fixed submaximal cadence and RPE rather than Hb, because altitude and hydration shift hemoglobin concentration. Track sleep, wellness, body mass, and oxygen saturation if available, but do not treat SpO2 as a diagnosis. Coordinate iron timing away from training if prescribed and monitor GI tolerance. Have a descent plan if fatigue or power worsen. Reassess at 7 days with the physician; if the athlete cannot tolerate the camp, return to lower altitude rather than pushing through. The judgement call is to protect the athlete’s health and the training block, not to force altitude adaptation on unresolved iron deficiency.